Methods
(1) Tissue level: The samples were
divided into the normotensive pregnancy (NP) group and severe
preeclampsia (SP) group. Hematoxylin-eosin staining, quantitative PCR,
Western blotting and immunohistochemistry
were performed.
(2) Cellular level: The samples were divided into the control group,
TRPV1 agonist group (capsaicin), and TRPV1 inhibitor group
(capsazepine), quantitative PCR and Western blotting were performed.